Delivering outcomes-led solutions with connected capabilities
November 8, 2021 | Behaviour change, Brand Strategy, Digital, Lucid Group, Medical Communications, Motion, creative, data analytics, healthcare communications, technology
Founded in 2007, Lucid Group has grown from a small UK-based medical education agency to a global healthcare consultancy and employs over 400 people with several offices in the UK and US.
We partner with the pharma and biotech industry to deliver pioneering solutions that change behaviour, improve clinical practice and advance health outcomes.
Through a relentless pursuit to increase the impact of our work, we pioneered the use of health psychology within medical communications to influence behaviour change, the impact was game-changing and demonstrated a paradigm shift in disease management and health outcomes.
Today we are a multi-capability healthcare consultancy working across the lifecycle. We have experience and deep scientific knowledge in a multitude of different therapy areas, culminating in many hundreds of years of combined knowledge and understanding.
By connecting our best-in-class capabilities and applying them at the right time we can better understand and fix healthcare problems with outcomes-led solutions — delivering life-transforming value for everyone.
Our core capabilities
We put brands front of mind. No matter where a brand or portfolio of brands may be in their lifecycle, our team of strategists, scientists, data analysts and creatives are masters in collaboration and brand building. Working together, we help our clients unlock potential with hidden truths to tell a story and create an experience that touches the hearts and minds of the audience.
Our deep understanding of the complex challenges and responsibilities of medical affairs today allows us to connect the perfect capabilities to create the perfect strategies for our clients. This is achieved via a robust and relevant scientific platform that realises the potential of assets, making sure the right medicines reach the right patients at the right time.
We combine our shared expertise to create scientific communication strategies and design aligned medical communication solutions. Our aim is to create scientific stories and experiences that are translated globally across affiliates and disseminated through the right channels to the right audiences to drive a meaningful difference in clinical practice and health outcomes.
Using the latest technology, we help our clients create joined-up experiences regardless of channel. Through audience-focused design, we can fuse digital and motion with our scientific and creative capabilities to provide compelling experiences that take the audience on a journey – empowering them to learn, understand and act.
We pioneer the use of health psychology to influence behaviour change within medical education. We apply our approach, Advance Outcomes™, to make sustained and meaningful improvements in clinical practice that improves health outcomes.​
We measure the impact of our work; establishing, tracking and benchmarking performance, and continually optimising results. From market performance to prescription and bespoke data sets, we translate complex data into meaningful insights and actionable strategy. We use data analytics to better understand operational performance, so we can apply the right capabilities at the right time to allow our clients to optimise their execution and improve health outcomes for patients.
For further information on our capabilities, or access to advice on healthcare communication challenges please get in touch with Clare Reynolds.
clare.reynolds@wearelucidgroup.com
This content was provided by Lucid Group Communications Limited
Company Details
Latest Content from Lucid Group Communications Limited
Lucid celebrate big wins at PMEA 2015
Success for Lucid at PMEA 2015
Lucid invests in their Futures programme with a new hire
Lucid Group continues their expansion
Janus kinase inhibitors are amongst the most read abstracts at the American College of Rheumatology 2015
Rheumatologists eagerly await trial data for Janus kinase inhibitors
Making a difference to patients with IBD
Changing lives with medical education
Lucid’s motivation to make a difference in medical education drives everything they do
Changing lives with medical education
Lucid Group meets with next generation MedEd talent at University of Oxford Internships Fair
Lucid Group will welcome interns in summer 2016
Lucid Group appoints new MD for Leading Edge
New MD at Leading Edge
Lucid Group showcases new KOL identification and mapping tool
Advancing Expert identification with digital new tool from Lucid Group
Lucid CEO discusses his inspiration and passion for changing patients’ lives
Changing patients' lives with innovative methodologies in medical education
Lucid Group starts new trend for CME in IBD education
A tailored educational event in IBD